Articles by Lisa Girion and Michael Erman

Jury Orders J&J to Pay $750 Million in Baby Powder Cancer Trial

Johnson & Johnson was ordered on Thursday by a New Jersey state jury to pay punitive damages of $750 million to four plaintiffs who allege that the company’s Baby Powder caused their cancer, a ruling that will be reduced to …

J&J CEO Testifies in Baby Powder Trial He Relied on Experts on Asbestos Risk

Johnson & Johnson Chief Executive Alex Gorsky on Monday faced questions from plaintiffs lawyers over the timing of his sale of company stock, as he testified for the first time in a jury trial over allegations that the company’s Baby …

Drugmakers Begin New Year by Raising Prices

Drugmakers including Bristol-Myers Squibb Co., Gilead Sciences Inc., and Biogen Inc. hiked U.S. list prices on more than 50 drugs on Wednesday, bringing total New Year’s Day drug price increases to more than 250, according to data analyzed by healthcare …

Industry Balks at Trump Rule to Let States Import Drugs from Canada

The Trump administration on Wednesday said it is proposing a rule to allow states to import prescription drugs from Canada, advancing a plan announced in July that the president has said will bring cheaper prescription drugs to Americans. Importation of …

Key Finance Committee Senators Unveil Bipartisan Drug Price Bill

The top Republican and Democrat on the U.S. Senate Finance Committee announced a proposal to lower prescription drug prices on Tuesday that could save $100 billion in costs to government healthcare programs, and said the committee would vote on the …

U.S. to Require Drug Companies to Disclose List Prices in TV Ads

The Trump administration on Wednesday said it will require drug makers to disclose the list price of prescription drugs in direct-to-consumer television advertisements, part of the government’s efforts to lower costs for U.S. consumers. The list price would be included …

Big Pharma Resuming U.S. Price Hikes in January After Pause: Reuters Report

Novartis AG and Bayer AG are among nearly 30 drugmakers that have taken steps to raise the U.S. prices of their medicines in January, ending a self-declared halt to increases made by a pharma industry under pressure from the Trump …

Co-Pay Tactic by Benefit Managers Credited with Cutting Prescription Drug Prices

A recently adopted tactic by U.S. health plans to limit the financial assistance drugmakers provide directly to consumers for prescription medicines is taking a toll on drug prices, according to a new analysis released on Tuesday. Real U.S. drug prices, …

Insurers, Hospitals Worry Republican Plan Makes Insurance Less Affordable

The House Republican health insurance plan suggests coverage after Obamacare will be less affordable, insurers and industry experts said on Tuesday, raising questions about whether Americans will enroll and insurance companies will enter the market. The draft legislation rolls back …

Anthem Not Giving Up on Merger with Cigna Even If Cigna Is

Anthem Inc. on Wednesday won a temporary restraining order that blocks smaller rival Cigna Corp. from officially terminating their proposed $54 billion merger, a transaction already rejected by U.S. antitrust regulators. Judge Travis Laster of Delaware’s Court of Chancery granted …